Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127049121 | 12704912 | 1 | I | 20160116 | 20160825 | 20160831 | 20160831 | EXP | FR-AFSSAPS-RE20160807 | FR-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-56016FF | BOEHRINGER INGELHEIM | 67.09 | YR | M | Y | 81.00000 | KG | 20160831 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127049121 | 12704912 | 1 | PS | VIRAMUNE | NEVIRAPINE | 1 | Oral | 400 MG | 201152 | 400 | MG | PROLONGED-RELEASE TABLET | QD | ||||||
| 127049121 | 12704912 | 2 | SS | EPIVIR | LAMIVUDINE | 1 | Oral | 150 MG | Y | 0 | 150 | MG | COATED TABLET | QD | |||||
| 127049121 | 12704912 | 3 | SS | EPIVIR | LAMIVUDINE | 1 | Oral | 50 MG | Y | 0 | 50 | MG | COATED TABLET | QD | |||||
| 127049121 | 12704912 | 4 | SS | ZIAGEN | ABACAVIR SULFATE | 1 | Oral | 600 MG | 0 | 300 | MG | COATED TABLET | BID | ||||||
| 127049121 | 12704912 | 5 | SS | NOVONORM | REPAGLINIDE | 1 | Oral | 1 MG | 0 | .5 | MG | TABLET | BID | ||||||
| 127049121 | 12704912 | 6 | SS | LASILIX SPECIAL | FUROSEMIDE | 1 | Oral | 125 MG | Y | 0 | 125 | MG | TABLET | QD | |||||
| 127049121 | 12704912 | 7 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | Oral | 1 ANZ | 0 | QD | |||||||||
| 127049121 | 12704912 | 8 | C | UVEDOSE | CHOLECALCIFEROL | 1 | Oral | 1111.1111 U | 0 | 100000 | IU | ORAL SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127049121 | 12704912 | 1 | HIV infection |
| 127049121 | 12704912 | 2 | HIV infection |
| 127049121 | 12704912 | 4 | HIV infection |
| 127049121 | 12704912 | 5 | Diabetes mellitus |
| 127049121 | 12704912 | 6 | Cardiac failure |
| 127049121 | 12704912 | 7 | Product used for unknown indication |
| 127049121 | 12704912 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127049121 | 12704912 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127049121 | 12704912 | Acute kidney injury | |
| 127049121 | 12704912 | Renal tubular necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |